Top Markets
#1 ADO Protocol ADO Protocol +193.44%
#2 Islamic Coin Islamic Coin +155.40%
#3 GoPlus Security GoPlus Security +43.47%
#4 GAIB AID GAIB AID +24.67%
#5 Casper Network Casper Network +15.03%
#6 Verus Coin Verus Coin +13.64%
#7 SkyAI SkyAI +13.54%
#8 Starpower Starpower +12.35%
#9 o1.exchange o1.exchange +11.59%
#10 Ontology Gas Ontology Gas +10.82%
Coin of the day
ADO Protocol ADO Protocol
Instellingen
Taal
DUTCH
Valuta
USD
Thema
NeoImmuneTech, Inc. NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

950220
Rang in aandelen #33498
As a clinical-stage biotechnology firm with a strong focus on T cells,... As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Aandeelprijs
$1.12
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$7.52M
Verandering (1 dag)
4.51%
Verandering (1 jaar)
-94.79%
Land
US
Handel NeoImmuneTech, Inc. (950220)

Categorie

Healthcare
Dividendrendementgeschiedenis voor NeoImmuneTech, Inc. (950220)
Het dividendrendement (TTM) van NeoImmuneTech, Inc. (aandelsymbool: 950220) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van NeoImmuneTech, Inc. (950220) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE